Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

Cynthia Comella¹, Joaquim J Ferreira^{2

3}, Emilie Pain⁴, Marion Azoulai⁴, Savary Om⁵

Affiliations

¹ Department of Neurology, Rush University Medical Center, 1725 West Harrison St. Suite 755, Chicago, IL, 60612, USA. Cynthia_Comella@rush.edu.
² Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
³ CNS, Campus Neurológico Sénior, Torres Vedras, Portugal.
⁴ Carenity, Paris, France.
⁵ Global Medical Affairs, Ipsen Pharma, Boulogne-Billancourt, France.

Published Erratum

Cynthia Comella et al. J Neurol. 2021 Mar.

. 2021 Mar;268(3):913.

doi: 10.1007/s00415-020-10255-1.

Cynthia Comella¹, Joaquim J Ferreira^{2

3}, Emilie Pain⁴, Marion Azoulai⁴, Savary Om⁵

¹ Department of Neurology, Rush University Medical Center, 1725 West Harrison St. Suite 755, Chicago, IL, 60612, USA. Cynthia_Comella@rush.edu.
² Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
³ CNS, Campus Neurológico Sénior, Torres Vedras, Portugal.
⁴ Carenity, Paris, France.
⁵ Global Medical Affairs, Ipsen Pharma, Boulogne-Billancourt, France.

No abstract available

Erratum for

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia.
Comella C, Ferreira JJ, Pain E, Azoulai M, Om S. Comella C, et al. J Neurol. 2021 Mar;268(3):903-912. doi: 10.1007/s00415-020-10217-7. Epub 2020 Sep 16. J Neurol. 2021. PMID: 32939574 Free PMC article.